Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVB-114 in Crohn's Perianal Fistulas
NCT04847739Phase 2Active, not recruiting
- Sponsor
- Avobis Bio
- Start
- Sep 2021
- Primary completion
- May 2025
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
A Phase 2 trial of AVB-114 in perianal fistula, sponsored by Avobis Bio. Started Sep 2021; status: active, not recruiting.
02
Drugs
AVB-114
03
Conditions
perianal fistula
Beyond the preview
Go deeper on NCT04847739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04847739.